Here is my take on the share price potential relat
Post# of 86984
(Total Views: 454)
Posted On: 10/13/2019 10:45:19 PM
Here is my take on the share price potential relative to Junebug's great recent post.
I did a quick look at three companies on OTC Markets .com. They are, Tilray -TLRY, Aphira - APHA and Aurara Cannabis - ACB.
I looked at Market Capitalization vs Revenues. The share price is not relevant in the basic comparison as the MCap is a function of outstanding shares multiplied by share price. The market capitalization, as we all know, is therefore the only way to get an idea of the upside potential in UNVC price, hence I did this comparison.
Tilray - current MC $1.7 billion, 80.1 million share O/S, 2018 revenues were $43.1 million. Market Cap to revenues = 39.3 times
Aphira - current MC $1.2 billion, 250.1 million share O/S, 2018 to 2019 year revs were $175.4 million. Market Cap to revs = 6.7 times
Aurara Cannabis - current MC $3.7 billion, 1.01 billion share O/S, 2018 to 2019 yr revs $189.7 million. Market Cap to revs = 19.6 times
Average of the three is 21.9 times revenue as the current market cap.
UNVC - Junebugs est. for HSI, PPSI, Wellness TD and RX is maybe $400 million. Take $400 million revs times 21.9 = $8.76 billion and divide by about 1.2 billion shares O/S and you get about $7.30 per share. That's just part of UNVC, JB pointed out the rest of the upside potential. Take the lowest of these three companies or take the highest of the three or take this average. Our potential is golden.
Another quick comparison, These three stocks were an average of 4.75 times higher in market cap just one year ago. You do the math.
Pretty nice numbers to think about. Just MHO, don't sell too soon.
Think pennies make pennies, think dollars make dollars, think big make big. I really do think we are going to be very happy with the UNVC price to come. The patience will be worth it, good luck to all.
I did a quick look at three companies on OTC Markets .com. They are, Tilray -TLRY, Aphira - APHA and Aurara Cannabis - ACB.
I looked at Market Capitalization vs Revenues. The share price is not relevant in the basic comparison as the MCap is a function of outstanding shares multiplied by share price. The market capitalization, as we all know, is therefore the only way to get an idea of the upside potential in UNVC price, hence I did this comparison.
Tilray - current MC $1.7 billion, 80.1 million share O/S, 2018 revenues were $43.1 million. Market Cap to revenues = 39.3 times
Aphira - current MC $1.2 billion, 250.1 million share O/S, 2018 to 2019 year revs were $175.4 million. Market Cap to revs = 6.7 times
Aurara Cannabis - current MC $3.7 billion, 1.01 billion share O/S, 2018 to 2019 yr revs $189.7 million. Market Cap to revs = 19.6 times
Average of the three is 21.9 times revenue as the current market cap.
UNVC - Junebugs est. for HSI, PPSI, Wellness TD and RX is maybe $400 million. Take $400 million revs times 21.9 = $8.76 billion and divide by about 1.2 billion shares O/S and you get about $7.30 per share. That's just part of UNVC, JB pointed out the rest of the upside potential. Take the lowest of these three companies or take the highest of the three or take this average. Our potential is golden.
Another quick comparison, These three stocks were an average of 4.75 times higher in market cap just one year ago. You do the math.
Pretty nice numbers to think about. Just MHO, don't sell too soon.
Think pennies make pennies, think dollars make dollars, think big make big. I really do think we are going to be very happy with the UNVC price to come. The patience will be worth it, good luck to all.
(9)
(0)